by NanoVation | Nov 19, 2024 | 2024, News
News NTx announces expansion of Board of Directors & completion of funding round led by Convergent Ventures Vancouver, British Columbia – November 19, 2024 –NanoVation Therapeutics, a platform company developing innovative technologies to overcome barriers to...
by NanoVation | Sep 18, 2024 | 2024, News
News NanoVation Therapeutics announces multi-target partnership with Novo Nordisk to develop genetic medicines targeting cardiometabolic and rare diseases NanoVation will receive research funding and is eligible to receive up to approximately US$600 million in...
by NanoVation | Aug 13, 2024 | 2024, 2024, News, Publications
Publication NTx chemistry team publishes in J. of Organic Chemistry Claisen Self-Condensation of Lactones in the Synthesis of Ionizable Lipids Nabi et al. 13 August 2024 Co-authored by NanoVation’s Ardalan Nabi, N. D. Prasad Atmuri, Deaglan Arnold, Fariba Saadati, Huy...
by NanoVation | Apr 8, 2024 | 2024, News
News Pieter Cullis inducted into Canadian Medical Hall of Fame We at NanoVation Therapeutics are proud to celebrate the remarkable achievements of our leGENEdary Co-Founder and Board Chair, Pieter Cullis! The Canadian Medical Hall of Fame (CMHF) has named Pieter as...
by NanoVation | Mar 4, 2024 | 2024, 2024, News, Publications
Publication NTx’s Drs. Dominik Witzigmann & Pieter Cullis publish in PNAS A magnetic separation method for isolating and characterizing the biomolecular corona of lipid nanoparticles Francia et al. 4 March 2024 Co-authored by NanoVation’s Drs Dominik Witzigmann...
by NanoVation | Jan 2, 2024 | 2024, News
News NanoVation Prof. Molly Stevens made a Dame NanoVation Scientific Advisor Molly Stevens has been appointed Dame of the Most Excellent Order of the British Empire for her outstanding services to Medicine. The entire NanoVation team congratulates Dr. Stevens for...
